<DOC>
	<DOCNO>NCT02238041</DOCNO>
	<brief_summary>The primary purpose Study evaluation safety accuracy GlucoClear CGM System .</brief_summary>
	<brief_title>GlucoClear ICU Study</brief_title>
	<detailed_description>Design : Non-randomized , non-treatment , prospective , open label Study . The GlucoClear System display real-time glucose value , glucose trend graph , glucose alarm either Study subject Study site clinical personnel . There treatment subject base output System . After provide write informed consent , subject meet inclusion/exclusion criterion monitor System maximum 72 hour . Up 51 1 mL blood sample draw subject comparative glucose measurement blood glucose analyzer 72 hour period . After GlucoClear Sensor removal , subject contact follow-up assessment 14 day later , subsequent adverse event document .</detailed_description>
	<criteria>18 year Surgical ICU surgical ICU plus intermediate care unit stay â‰¥ 24 hour Signed consent Transplant patient End stage medical condition disease Restricted venous access History HIT heparin allergy Contraindication anticoagulation Positive pregnancy test In another study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Glucose monitoring</keyword>
	<keyword>Intensive care unit</keyword>
</DOC>